(Recasts, adds CEO comment, detail)
LONDON (Thomson Financial) - Shire Ltd. upped its guidance for 2008 revenue growth be at least 20 percen
[31 Jul '08]
LONDON (Thomson Financial) - Shire Ltd. upped its guidance for 2008 revenues to be at least 20 percent above year ago-levels as it delievered a
[31 Jul '08]
LONDON (Thomson Financial) - Leading shares are expected to open a touch firmer Thursday, building on Wall Street's gains overnight but with sen
[31 Jul '08]
LONDON (Thomson Financial) - Biopharmaceutical company Shire Limited said non-executive director Robin Buchanan will step down from the board of
[21 Jul '08]
LONDON (Thomson Financial) - Jerini AG, which Shire Ltd. is buying for 328 million euros, has received approval from the European Commission to
[15 Jul '08]
(Adds analyst comment)
LONDON (Thomson Financial) - Shire Plc., the specialty pharmaceutical company, is set to acquire Berlin-based biotech
[3 Jul '08]
(Adds CEO comment, detail throughout)
LONDON (Thomson Financial) - Shire Plc., the specialty pharmaceutical company, is set to acquire Berli
[3 Jul '08]
LONDON (Thomson Financial) - Shire Plc, the specialty pharmaceutical company, is set to acquire Berlin-based biotechnology company Jerini AG in
[3 Jul '08]